Table 4. Type of recurrence in patients with sentinel lymph node biopsy only group after neoadjuvant chemotherapy in cytology-proven node positive disease.
| Case | Recurrence | DFS time (mo) | HR status | HER2 status | Breast pCR | No. of retrieved SLNs |
|---|---|---|---|---|---|---|
| 1 | Brain | 5 | Negative | Positive | Yes | 3 |
| 2 | Brain | 6 | Positive | Positive | No | 3 |
| 3 | SCN | 6 | Positive | Negative | Yes | 4 |
| 4 | SCN | 7 | Negative | Negative | No | 5 |
| 5 | Axillary | 10 | Negative | Negative | No | 2 |
DFS=disease-free survival; HR=hormone receptor; HER2=human epidermal growth factor receptor 2; pCR=pathological complete remission; SLN=sentinel lymph node; SCN=supraclavicular node.